We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Correspondence and Brief Communications |

Systemic Inflammatory Response Syndrome and Magic Bullets: Finding the Target and Improving the Aim

Peter Gosling, PhD; John U. Bascom, MD; Bashir A. Zikria, MD
Arch Surg. 1998;133(3):334. doi:.
Text Size: A A A
Published online


We read with interest the review article by Dr Baue1 in which he describes so clearly the problems with studies of new modulators of inflammation aimed at preventing systemic inflammatory response syndrome (SIRS) in patients in the intensive care unit, the limitations of single anti-inflammatory therapies, and the need for early identification of patients at risk.

He correctly points out the shortcomings of trials of powerful modulators of inflammation in patients with a wide variety of diseases and disease severity, and recommends more critical patient selection for inclusion in therapeutic trials. This includes "rapidly identifying circulating endotoxin (by a lipopolysaccharide assay), Gram-negative bacteremia (by rapid culture techniques), and . . . elevated mediator levels, such as interleukin 6 or TNF [tumor necrosis factor]. . . ." However, because individual mediator levels change rapidly and have overlapping functions, even if rapid bedside patient measurement were possible, it may not identify those patients at risk of SIRS.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Value of Multivariable Scores for Prediction of Bloodstream Infections

The Rational Clinical Examination: Evidence-Based Clinical Diagnosis
Quick Reference